Toxic effects of hexane derivatives on cultured rat Schwann cells

Toxicology

Volumn 108, Issue 1-2, 1996, Pages 25-31

  Kamijima, Michihiro ^a   Sobue, Gen ^a   Ichihara, Gaku ^a   Shibata, Eiji ^a   Ono, Yuichiro ^a   Kondo, Hidetaka ^a   Villanueva, Maria Beatriz G ^a   Itoh, Takayuki ^a   Mitsuma, Terunori ^b   Takeuchi, Yasuhiro ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

2,5 Dimethylfuran; 2,5 Hexanedione; Cell culture; Mitosis; Schwann

Indexed keywords

2 HEXANOL; 2 HEXANONE; 2,5 DIMETHYLFURAN; ACETONYLACETONE; ALKANE DERIVATIVE; GAMMA VALEROLACTONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; MITOSIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SCHWANN CELL;

ANIMALIA;

EID: 0029930572     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(95)03267-J     Document Type: Article

References (38)

1. Baker, T.S. and Rickert, D.E. (1981) Dose-dependent uptake, distribution, and elimination of inhaled n-hexane in the Fischer-344 rat. Toxicol. Appl. Pharmacol. 61, 414-422.
2. Boegner, F., Gruning, W., Stoltenburg-Didinger, G., Marx, P. and Altenkirch, H. (1992) 2,5-Hexanedione is a potent gliatoxin in in vitro cell cultures of the nervous system. Neurotoxicology 13, 151-154.
3. Chapin, R.E., Morgan, K.T. and Bus, J.S. (1983) The morphogenesis of testicular degeneration induced in rats by orally administered 2,5-hexanedione. Exp. Mol. Pathol. 38, 149-169.
4. Doyu, M., Sobue, G., Ken, E., Kimata, K., Shinomura, T., Yamada, Y., Mitsuma, T. and Takahashi, A. (1993) Laminin A, B1, and B2 chain gene expression in transected and regenerating nerves: regulation by axonal signals. J. Neurochem. 60, 543-551.
5. Durham, H.D. (1988) Aggregation of intermediate filaments by 2,5-hexanedione: Comparison of effects on neurofilaments, GFAP-filaments and vimentin-filaments in dissociated cultures of mouse spinal cord-dorsal root ganglia. J. Neuropathol. Exp. Neurol. 47, 432-442.
6. Durham, H.D., Pena, S.D.J. and Carpenter, S. (1983) The neurotoxins 2,5-hexanedione and acrylamide promote aggregation of intermediate filaments in cultured fibroblast. Muscle Nerve 6, 631-637.
7. Durham, H.D., Pena, S.D.J. and Ecobichon, D.J. (1988) Hexahydrocarbon effects on intermediate filament organization in human fibroblasts. Muscle Nerve 11, 160-165.
8. Durham, H.D., Salera, I. and Dahrouge, S. (1989) Evidence that formation of an intermediate filament-protein complex plays a role in aggregation of neurofilaments, glial fibrillary acidic protein (GFAP)-filaments and vimentin-filaments by 2,5-hexanedione. J. Neuropathol. Exp. Neurol. 48, 197-211.
9. Fedtke, N. and Bolt, H.M. (1987) 4,5-Dihydroxy-2-hexanone: a new metabolite of n-hexane and of 2,5-hexanedione in rat urine. Biomed. Environ. Mass Spectrom. 14, 563-572.
10. Hall, S.M. and Gregson, N.A. (1982) The effects of 2,5-hexane dione on remyelination in the peripheral nervous system of the mouse. J. Neuropathol. Exp. Neurol. 41(6), 642-651.
11. Krasavage, W.J., O'Donoghue, J.L., DiVincenzo, G.D. and Terhaar, C.J. (1980) The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. Toxicol. Appl. Pharmacol. 52, 433-441.
12. Kreider, B., Messing, A., Doan, H., Kim, S.U., Lisak, R.P. and Pleasure, D. (1981) Enrichment of Schwann cell cultures from neonatal rat sciatic nerve by differential adhesion. Brain Res. 207, 433-444.
13. Malorni, W., Formisano, G. and Molinari, A. (1987) In vitro effects of 2,5-hexanedione on a melanoma cell line: a morphological study. Toxicology 43, 269-282.
14. Malorni, W., Formisano, G. and Donelli, G. (1989) Morphologic changes induced in vitro by 2,5 hexanedione. In Vitro Cell Dev. Biol. 25, 82-90.
15. Mendell, J.R., Saida, K., Ganansia, M.F., Jackson, D.B., Weiss, H., Gardier, R.W., Chrisman, C., Allen, N., Couri, D., O'Neill, J., Marks, B. and Hetland, L. (1974) Toxic polyneuropathy produced by methyl-n-butyl ketone. Science 185, 787-789.
16. Moretto, G., Monaco, S., Passarin, M.G., Benedetti, M.D. and Rizzuto, N. (1991) Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro. Arch. Toxicol. 65, 409-413.
17. 2+ homeostasis. Toxicol. Appl. Pharmacol. 117, 180-188.
18. Nagano, M., Sato, K., Eto, K., Misumi, J. and Nomura, S. (1983) An experimental study on electrophysiological and histopathological changes in 2,5-hexanedione-intoxicated rats. Jpn. J. Ind. Health 25, 77-83.
19. Politis, M.J., Pellegrino, R.G. and Spencer, P.S. (1980) Ultrastructural studies of the dying-back process. V. Axonal neurofilaments accumulate at sites of 2,5-hexanedione application: evidence for nerve fibre dysfunction in experimental hexacarbon neuropathy. J. Neurocytol, Psychiatry 9, 505-516.
20. Powell, H.C., Koch, T., Garrett, R. and Lampert, P.W. (1978) Schwann cell abnormalities in 2,5-hexanedione neuropathy. J. Neurocytol. 7, 517-528.
21. Raff, M.C., Hornby-Smith, A. and Brockes, J.P. (1978) Cyclic AMP is a mitogenic signal for cultured rat Schwann cells. Nature 273, 672-673.
22. Sager, P.R. (1989) Cytoskeletal effects of acrylamide and 2,5-hexanedione: selective aggregation of vimentin filaments. Toxicol. Appl. Pharmacol. 97, 141-155.
23. Saito, I., Shibata, E., Huang, J., Hisanaga, N., Ono, Y. and Takeuchi, Y. (1991) Determination of urinary 2,5-hexanedione concentration by an improved analytical method as an index of exposure to n-hexane. Br. J. Ind. Med. 48, 568-574.
24. Selkoe, D.J., Luckenbill-Edds, L. and Shelanski, M.L. (1978) Effects of neurotoxic industrial solvents on cultured neuroblastoma cells: methyl n-buthyl ketone, n-hexane and derivatives. J. Neuropathol. Exp. Neurol. 37, 768-789.
25. Shibata, E., Huang, J., Hisanaga, N., Ono, Y., Saito, I. and Takeuchi, Y. (1990) Effects of MEK on kinetics of n-hexane metabolites in serum. Arch. Toxicol. 64, 247-250.
26. Sobue, G. and Pleasure, D. (1984) Schwann cell galactocerebroside induced by derivatives of adenosine 3′,5′-monophosphate. Science 224, 72-74.
27. Sobue, G. and Pleasure, D. (1985a) Adhesion of axolemmal fragments to Schwann cells: signal-and target-specific process closely linked to axolemmal induction of Schwann cell mitosis. J. Neurosci. 5, 379-387.
28. Sobue, G. and Pleasure, D. (1985b) Experimental lead neuropathy: inorganic lead inhibits proliferation but not differentiation of Schwann cells. Ann. Neurol. 17, 462-468.
29. Sobue, G., Kreider, B., Asbury, A. and Pleasure, D. (1983) Specific and potent mitogenic effect of axolemmal fraction on Schwann cells from rat sciatic nerves in serum-containing and defined media. Brain Res. 280, 263-275.
30. Sobue, G., Shuman, S. and Pleasure, D. (1986) Schwann cell responses to cyclic AMP: Proliferation, change in shape, and appearance of surface galactocerebroside. Brain Res. 362, 23-32.
31. Spencer, P.S. and Schaumburg, H.H. (1975) Experimental neuropathy produced by 2,5-hexanedione - a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone. J. Neurol. Neurosurg., Psychiatry 38, 771-775.
32. 14C]-2,5-hexanedione in hens. Drug Metab. Dispos. 15, 779-785.
33. Thomas, P.K., Landon, D.N. and King, R.H.M. (1992) Diseases of the peripheral nerves. In: J.H. Adams and L.W. Duchen (Eds), Greenfield's Neuropathology, 5th edn., Edward Arnold, London, pp. 1116-1245.
34. Veronesi, B., Peterson, E.R., Bornstein, M.B. and Spencer, P.S. (1983) Ultrastructural studies of the dying-back process. VI. Examination of nerve fibers undergoing giant axonal degeneration in organotypic culture. J. Neuropathol. Exp. Neurol. 42, 153-65.
35. Wada, Y., Okamoto, S. and Takagi, S. (1965) Intoxication polyneuropathy following exposure to n-hexane. Rinsyo Sinkeigaku (Clinical Neurology) 5, 591-598.
36. Wolfe, S.L. (1993) Microtubules and microtubule-based cell motility; The cell cycle, cell cycle regulation, and cancer. In: Molecular and Cellular Biology, Wadsworth Publishing Company, Belmont, CA, pp. 416-450, 909-950.
37. Yamada, S. (1967) Intoxication polyneuritis in the workers exposed to n-hexane. Jpn. J. Ind. Health 9, 651-659.
38. Yamamura, Y. (1969) n-Hexane polyneuropathy. Folia Psychiatr. Neurol. Jpn. 23, 45-57.